
JNJ Stock Forecast & Price Target
JNJ Analyst Ratings
Bulls say
Johnson & Johnson is well-positioned for future growth with a diverse portfolio and focus on innovative medicine and medtech. The company's strong pipeline and global expansion plans, in addition to commitment to shareholder returns and sustainability, make it an attractive investment option. However, competition and drug pricing reform may present challenges for JNJ.
Bears say
Johnson & Johnson is currently facing a challenging legal landscape due to ongoing litigation related to talc powder and opioid products. The company's restructurings and divestment of its consumer business may also impact its financials in the short term. Additionally, the slow pace of new product launches in its innovative medicine and medtech divisions may limit potential upside to current estimates. Overall, the company's current growth drivers and product pipeline may not be strong enough to counteract these headwinds, leading to a negative outlook.
This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.
JNJ Analyst Forecast & Price Prediction
Start investing in JNJ
Order type
Buy in
Order amount
Est. shares
0 shares